Insiders · ERNA

Brant Binder

Insider at Eterna Therapeutics Inc. (ERNA) since July 2023

Brant Binder has filed 3 insider reports with the SEC since July 2023, as insider at Eterna Therapeutics Inc. (ERNA). The latest filing, on August 10, 2023, reports a change in holdings at Eterna Therapeutics Inc. (ERNA).

Filings
3
Companies
1
Bought on market
None
Sold on market
None

Companies where Brant Binder is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Eterna Therapeutics Inc. logo
ERNA
Eterna Therapeutics Inc.
Insidersince July 2023$1.68Aug 10, 2023

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Brant Binder with

Other insiders at the same companies

Questions about Brant Binder

What is Brant Binder's role at Eterna Therapeutics Inc.?
Brant Binder reports to the SEC as insider at Eterna Therapeutics Inc. (ERNA), according to the latest filing on August 10, 2023.
Has Brant Binder bought or sold stock recently?
No open-market purchases or sales by Brant Binder are on file. The filings report open-market purchase.
How do I get alerts when Brant Binder files?
Follow Brant Binder on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Brant Binder (SEC CIK 0001133594). Totals count each trade once, skipping amendments whose original is on file, from Jul 11, 2023 on. View on SEC EDGAR